Overview

Short-term Sedation With Remimazolam Besylate in Patients Receiving Invasive Mechanical Ventilation

Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
A randomized non-inferior trial comparing remimazolam besylate with propofol for short-term sedation during invasive mechanical ventilation in intensive care units
Phase:
Phase 3
Details
Lead Sponsor:
Wuhan Union Hospital, China
Collaborator:
Yichang Humanwell Pharmaceutical Co., Ltd., China
Treatments:
Propofol
Remifentanil